Invenomic Capital Management LP boosted its stake in shares of Lexaria Bioscience Corp. (NASDAQ:LEXX Free Report) by 62.0% in the second quarter, according to its most recent disclosure with...
KELOWNA, BC / ACCESSWIRE / December 7, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, announces that the...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
DehydraTECHTM-powered semaglutide achieved these benefits in a human pilot study compared to Rybelsus:Sustained lower levels of blood glucose from baseline including nearly 10x lower after 24...
DehydraTECHTM-powered semaglutide achieved these benefits in a human pilot study compared to Rybelsus:Sustained higher levels of semaglutide in blood;Faster achievement of peak drug delivery...
Lexaria Bioscience Corp. (NASDAQ:LEXX Get Free Report)s stock price shot up 9% during trading on Tuesday . The company traded as high as $1.75 and last traded at $1.69. 243,994 shares...
Get Ready for Next Generation of Diabetes, Weight-Management Drugs Get Ready for Next Generation of Diabetes, Weight-Management Drugs PR Newswire NEW YORK, Nov. 1, 2023 NetworkNewsWire Editorial...
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, Can Diabetes, Weight-Loss Drugs Get Even...
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via InvestorWire Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60...
Can Diabetes, Weight-Loss Drugs Get Even Better Can Diabetes, Weight-Loss Drugs Get Even Better PR Newswire NEW YORK, Oct. 30, 2023 NetworkNewsWire Editorial Coverage NEW YORK, Oct. 30, 2023...